Literature DB >> 8299365

Side effects of topical glucocorticoids.

C M Mills1, R Marks.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8299365     DOI: 10.1159/000422371

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


× No keyword cloud information.
  6 in total

1.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

2.  Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.

Authors:  Stefanie Schoepe; Heike Schäcke; Khusru Asadullah
Journal:  Dermatoendocrinol       Date:  2011-07-01

3.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

4.  DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner.

Authors:  Junguo Zhou; Robert H Oakley; John A Cidlowski
Journal:  Mol Endocrinol       Date:  2008-04-16

5.  A Case of Darier's Disease with a Novel Missense Mutation in ATP2A2 Successfully Treated with Calcipotriol/Betamethasone Dipropionate Two-Compound Ointment.

Authors:  Teppei Hagino; Hajime Nakano; Hidehisa Saeki; Naoko Kanda
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-03-05

6.  The 15d‑PGJ2 hydrogel ameliorates atopic dermatitis through suppression of the immune response.

Authors:  Marcelo H Napimoga; Juliana T Clemente-Napimoga; Nina M Machabanski; Maria Eduarda A Juliani; Pedro Henrique B C Acras; Cristina G Macedo; Henrique B Abdalla; Antônio José de Pinho; Andresa B Soares; Marcelo Sperandio; Daniele R de Araújo
Journal:  Mol Med Rep       Date:  2019-04-11       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.